Abstract
I. Introduction:
Tear film plays an important part in the maintenance of intact ocular surface with their anti-microbial, nourishing, mechanical and optical properties. Components of tears include growth factors, fibronectin and vitamins to support proliferation, migration and differentiation of the corneal and conjunctival epithelium. Depletion in quantity or quality of tears can lead to various changes like squamous metaplasia, epithelial defects and infections of corneal epithelium. Artificial tears used in treatment of dry eye provide lubrication to the ocular surface, but they fall short of functioning as tears due to lack of nutrients and factors present in natural tears. Autologous serum drops being prepared from patient's body fluids are thus non-allergic and their biomechanical and biochemical properties are similar to normal tears. Their use in keratoconjunctivitis sicca was first described by Fox et al [1] in 1984 in their search for tear substitute free of potentially harmful preservatives. Later, Tsubota et al [2] reported that growth factors and vitamins present in serum eye drops have true epitheliotropic potential for ocular surface in sjogren's syndrome.
II. Material and methods:
Twenty six eyes of thirteen severe dry eye patients were enrolled in this study. 
III.
Observations: 
IV. Results:
Twenty six eyes of thirteen patients belonging to age group of 25-65 years suffering from severe dry were evaluated. Of these, nine were female (69.23%) and four were male (30.76%). All patients had grittiness and foreign body sensation as presenting complaints, and were on some form of lubricants for treatment. Mean duration of their treatment with lubricants was 24.57+/-12.7 months.
At baseline, Schirmer's test results were subnormal in all patients (mean 1.63mm), BUT was less than or equal to 5 seconds (mean 4.18). All patients had positive staining at baseline. On first follow-up at two weeks of treatment, mean Schirmer's score was 3.43mm and value of mean BUT was found to be 6.62 seconds. There was substantial improvement in ocular surface disease as evidenced by mild or moderate staining in 18 eyes after treatment while 8 eyes continued to have severe staining. On last follow-up at six weeks, 22 eyes were symptom free, mean Schirmer's score recorded was 5.96mm, mean BUT was 9.08 seconds. Though all eyes showed evidence of ocular surface staining but there was shift noted in 22 eyes from severe to either mild or moderate degree. No complications were reported in this study.
V.
Discussion:
This study confirms the beneficial effects of autologous serum in patients with severe dry eye. Although the number of patients enrolled in this study is not large, the improvements seen were clinically and statistically significant. Serum contains various factors that are also present in tears including vitamin A, epidermal growth factors, substance P, as well as proteins such as lactoferrins and lysozymes [3] . All these factors are essential for healthy functioning of ocular surface. Biochemical properties of normal human tears and serum are approximately similar with vitamin A, fibronectin, transforming growth factor beta been more in serum and surface immunoglobulin A more in tears [4] . Also, there is no difference between growth factor levels of autologous serum of dry eye syndrome and normal person [5] . Transforming growth factor beta is also believed to control epithelial proliferation and to maintain cells in undifferentiated state. Neural factors such as substance P are important for corneal epithelial migration. Human serum stimulates corneal fibroblast migration, proliferation and matrix metalloproteinase activity [6] . Presence of oil in serum may act as a replacement for lipid tear component produced by the meibomian glands. Impression cytology studies also suggest that autologous serum leads to upregulation of goblet cells and mucin expression in a dose dependent manner [7] . Autologous serum eyedrops improve conjunctival status too in dry eye syndrome patients [8] . Severe dry eye and ocular surface disease constitute a major management challenge. In this study, patients had significant improvement both subjectively and objectively after using autologous serum for six weeks.
VI.

Conclusion:
Autologous serum eyedrops were found effective and safe in treatment of severe dry eye disease, as evidenced by improvement in subjective assessment of symptoms, Schirmer's score, tear film break-up time and ocular surface staining.
